SCHEMBL21941476

SCHEMBL21941476

C[C@@H](Oc1cnc2[nH]cc(C=O)c2n1)c1cc(F)ccc1OCCN(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 1/20 0.38
▸ ADRB2 P07550 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ NTRK1 P04629 1/20 0.35
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ ROCK2 O75116 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TMEM97 Q5BJF2 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ PADI4 Q9UM07 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CDC42BPA Q5VT25 1/20 0.31
▸ CDC7 O00311 1/20 0.31
▸ ALK Q9UM73 1/20 0.30
▸ ADORA2A P29274 1/20 0.30
▸ ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16946794 0.77 RBP4 (0.34) TDO2JAK2JAK1JAK3ROCK2
SCHEMBL20903528 0.77 — —
SCHEMBL16946791 0.76 TRPA1 (0.35) JAK2JAK1JAK3KDM4EALK
SCHEMBL18352377 0.76 TRPA1 (0.35) JAK2JAK1JAK3KDM4EALK
SCHEMBL21941539 0.76 — —
SCHEMBL30304109 0.70 ALDH1A1 (0.49) ADRB2ADRB1HRH1KDM4EALDH1A1
SCHEMBL29189194 0.70 ALDH1A1 (0.49) ADRB2ADRB1HRH1KDM4EALDH1A1
SCHEMBL21941188 0.68 INPPL1 (0.39) NTRK1ALK
SCHEMBL18357995 0.65 RBP4 (0.33) NTRK1ALK
SCHEMBL12253038 0.64 KDM4E (0.49) HRH1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3636650-A1 DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES Turning Point Therapeutics, Inc. (US) 2020-04-15 — — EP disclosed
EP-3636649-A1 DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES Turning Point Therapeutics, Inc. (US) 2020-04-15 — — EP disclosed
Send feedback